FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff
By
McKnight's Staff
Jun 19, 2013
Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers,...
Clinical briefs for Monday, Oct. 5
By
Alicia Lasek
Oct 05, 2020
Blood pressure meds reduce mortality in flu and pneumonia, study finds … Purpose in life linked to fewer dementia-related problems … Poor cognitive performance predicts impaired activities of daily...
Efforts to combat Clostridium difficile are coming up short, survey finds
By
McKnight's Staff
Mar 12, 2013
Long-term care operators and other healthcare providers are having limited success in combating Clostridium difficile infections, despite increasing their efforts in the last three years, according to...
HHS healthcare-associated infection reduction plan is open for public comments
By
McKnight's Staff
Apr 20, 2012
The Department of Health and Human Services is seeking public comments on its updated action plan — which includes efforts in nursing homes — to reduce or eliminate healthcare-associated infections.
The gift of gallows humor
By
Mary Gustafson
Oct 11, 2012
Comedienne Tig Notaro — from what I’ve been able to glean in my relatively brief history as a fan of her comedy — does not appear to have any connection with the long-term care industry. But...
C. diff vaccine moves closer to reality with launch of large Phase III trial
By
Tim Mullaney
May 19, 2014
A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes...
Acute, post-acute partnerships reduce C. diff about 50% in Washington state
By
Tim Mullaney
Mar 25, 2014
Hospitals and post-acute facilities in Washington state have cut their rate of Clostridium difficile infections in half since 2012 by partnering with each other in a robust infection control program, according...
Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
Fecal transplants to treat C. diff now need FDA approval
By
McKnight's Staff
May 17, 2013
The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.
FDA — full of poop?
By
Jacqueline Vance, RNC, CDONA/LTC
Jun 11, 2013
Every few days I read the Food and Drug Administration (FDA) news to see if there is anything relevant to eldercare that I should be aware of. Recently, I came across an extremely eye-opening item.